LMNB1_HUMAN - dbPTM
LMNB1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LMNB1_HUMAN
UniProt AC P20700
Protein Name Lamin-B1
Gene Name LMNB1
Organism Homo sapiens (Human).
Sequence Length 586
Subcellular Localization Nucleus inner membrane
Lipid-anchor
Nucleoplasmic side.
Protein Description Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin..
Protein Sequence MATATPVPPRMGSRAGGPTTPLSPTRLSRLQEKEELRELNDRLAVYIDKVRSLETENSALQLQVTEREEVRGRELTGLKALYETELADARRALDDTARERAKLQIELGKCKAEHDQLLLNYAKKESDLNGAQIKLREYEAALNSKDAALATALGDKKSLEGDLEDLKDQIAQLEASLAAAKKQLADETLLKVDLENRCQSLTEDLEFRKSMYEEEINETRRKHETRLVEVDSGRQIEYEYKLAQALHEMREQHDAQVRLYKEELEQTYHAKLENARLSSEMNTSTVNSAREELMESRMRIESLSSQLSNLQKESRACLERIQELEDLLAKEKDNSRRMLTDKEREMAEIRDQMQQQLNDYEQLLDVKLALDMEISAYRKLLEGEEERLKLSPSPSSRVTVSRASSSRSVRTTRGKRKRVDVEESEASSSVSISHSASATGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTASPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTTIPEEEEEEEEAAGVVVEEELFHQQGTPRASNRSCAIM
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MATATPVPP
------CCCCCCCCC
13.1222223895
3Phosphorylation-----MATATPVPPR
-----CCCCCCCCCC
29.7530108239
5Phosphorylation---MATATPVPPRMG
---CCCCCCCCCCCC
22.0623401153
10MethylationTATPVPPRMGSRAGG
CCCCCCCCCCCCCCC
35.70115481603
13PhosphorylationPVPPRMGSRAGGPTT
CCCCCCCCCCCCCCC
15.0423403867
14MethylationVPPRMGSRAGGPTTP
CCCCCCCCCCCCCCC
31.3624129315
19PhosphorylationGSRAGGPTTPLSPTR
CCCCCCCCCCCCHHH
44.3029255136
20PhosphorylationSRAGGPTTPLSPTRL
CCCCCCCCCCCHHHH
25.9329255136
23PhosphorylationGGPTTPLSPTRLSRL
CCCCCCCCHHHHHHH
25.9819664994
25PhosphorylationPTTPLSPTRLSRLQE
CCCCCCHHHHHHHHH
40.6529255136
28O-linked_GlycosylationPLSPTRLSRLQEKEE
CCCHHHHHHHHHHHH
27.8828510447
28PhosphorylationPLSPTRLSRLQEKEE
CCCHHHHHHHHHHHH
27.8826055452
33AcetylationRLSRLQEKEELRELN
HHHHHHHHHHHHHHH
43.4523749302
33UbiquitinationRLSRLQEKEELRELN
HHHHHHHHHHHHHHH
43.4519608861
42MethylationELRELNDRLAVYIDK
HHHHHHHHHHHHHHH
24.39115481619
46PhosphorylationLNDRLAVYIDKVRSL
HHHHHHHHHHHHHCC
9.59-
49AcetylationRLAVYIDKVRSLETE
HHHHHHHHHHCCCCC
29.9523749302
49UbiquitinationRLAVYIDKVRSLETE
HHHHHHHHHHCCCCC
29.9521890473
52PhosphorylationVYIDKVRSLETENSA
HHHHHHHCCCCCCCC
33.2828450419
55PhosphorylationDKVRSLETENSALQL
HHHHCCCCCCCCEEE
45.8422817901
58PhosphorylationRSLETENSALQLQVT
HCCCCCCCCEEEEEE
24.9128450419
76PhosphorylationEVRGRELTGLKALYE
HHCCCCCHHHHHHHH
35.4024247654
79AcetylationGRELTGLKALYETEL
CCCCHHHHHHHHHHH
37.3825953088
79UbiquitinationGRELTGLKALYETEL
CCCCHHHHHHHHHHH
37.3821890473
82NitrationLTGLKALYETELADA
CHHHHHHHHHHHHHH
26.18-
82PhosphorylationLTGLKALYETELADA
CHHHHHHHHHHHHHH
26.1828152594
84PhosphorylationGLKALYETELADARR
HHHHHHHHHHHHHHH
23.8124719451
102SumoylationDTARERAKLQIELGK
HHHHHHHHHHHHHCC
47.33-
102AcetylationDTARERAKLQIELGK
HHHHHHHHHHHHHCC
47.3325953088
102MalonylationDTARERAKLQIELGK
HHHHHHHHHHHHHCC
47.3326320211
102SumoylationDTARERAKLQIELGK
HHHHHHHHHHHHHCC
47.3328112733
102UbiquitinationDTARERAKLQIELGK
HHHHHHHHHHHHHCC
47.3321906983
109AcetylationKLQIELGKCKAEHDQ
HHHHHHCCCHHHHHH
45.2325953088
109UbiquitinationKLQIELGKCKAEHDQ
HHHHHHCCCHHHHHH
45.23-
111AcetylationQIELGKCKAEHDQLL
HHHHCCCHHHHHHHH
61.3623236377
111UbiquitinationQIELGKCKAEHDQLL
HHHHCCCHHHHHHHH
61.36-
121NitrationHDQLLLNYAKKESDL
HHHHHHHHHHHHHHC
21.55-
123AcetylationQLLLNYAKKESDLNG
HHHHHHHHHHHHCCC
46.8719608861
123SuccinylationQLLLNYAKKESDLNG
HHHHHHHHHHHHCCC
46.8723954790
123SumoylationQLLLNYAKKESDLNG
HHHHHHHHHHHHCCC
46.8728112733
123UbiquitinationQLLLNYAKKESDLNG
HHHHHHHHHHHHCCC
46.8721890473
124AcetylationLLLNYAKKESDLNGA
HHHHHHHHHHHCCCC
55.0426051181
124UbiquitinationLLLNYAKKESDLNGA
HHHHHHHHHHHCCCC
55.04-
126PhosphorylationLNYAKKESDLNGAQI
HHHHHHHHHCCCCHH
57.1723401153
134AcetylationDLNGAQIKLREYEAA
HCCCCHHHHHHHHHH
29.4325953088
134UbiquitinationDLNGAQIKLREYEAA
HCCCCHHHHHHHHHH
29.4321890473
138PhosphorylationAQIKLREYEAALNSK
CHHHHHHHHHHHCCH
12.3928152594
144PhosphorylationEYEAALNSKDAALAT
HHHHHHCCHHHHHHH
32.5327251275
145SumoylationYEAALNSKDAALATA
HHHHHCCHHHHHHHH
50.7628112733
145UbiquitinationYEAALNSKDAALATA
HHHHHCCHHHHHHHH
50.7621890473
156AcetylationLATALGDKKSLEGDL
HHHHHCCHHHHCCCH
42.3325953088
156UbiquitinationLATALGDKKSLEGDL
HHHHHCCHHHHCCCH
42.33-
157AcetylationATALGDKKSLEGDLE
HHHHCCHHHHCCCHH
66.0819608861
157SumoylationATALGDKKSLEGDLE
HHHHCCHHHHCCCHH
66.0828112733
157UbiquitinationATALGDKKSLEGDLE
HHHHCCHHHHCCCHH
66.0821890473
158PhosphorylationTALGDKKSLEGDLED
HHHCCHHHHCCCHHH
37.0828355574
167UbiquitinationEGDLEDLKDQIAQLE
CCCHHHHHHHHHHHH
60.97-
176PhosphorylationQIAQLEASLAAAKKQ
HHHHHHHHHHHHHHH
14.7928555341
181AcetylationEASLAAAKKQLADET
HHHHHHHHHHHCCCH
36.0019608861
181SuccinylationEASLAAAKKQLADET
HHHHHHHHHHHCCCH
36.0023954790
181SumoylationEASLAAAKKQLADET
HHHHHHHHHHHCCCH
36.0028112733
181UbiquitinationEASLAAAKKQLADET
HHHHHHHHHHHCCCH
36.0019608861
182AcetylationASLAAAKKQLADETL
HHHHHHHHHHCCCHH
45.9026051181
182UbiquitinationASLAAAKKQLADETL
HHHHHHHHHHCCCHH
45.9021890473
188PhosphorylationKKQLADETLLKVDLE
HHHHCCCHHHHCCHH
37.6329496963
191AcetylationLADETLLKVDLENRC
HCCCHHHHCCHHHHH
36.4926051181
197MethylationLKVDLENRCQSLTED
HHCCHHHHHHHHHHC
15.52115481651
198GlutathionylationKVDLENRCQSLTEDL
HCCHHHHHHHHHHCH
4.9322555962
200PhosphorylationDLENRCQSLTEDLEF
CHHHHHHHHHHCHHH
40.6723401153
202PhosphorylationENRCQSLTEDLEFRK
HHHHHHHHHCHHHHH
32.4723403867
209AcetylationTEDLEFRKSMYEEEI
HHCHHHHHHHHHHHH
44.9125825284
209UbiquitinationTEDLEFRKSMYEEEI
HHCHHHHHHHHHHHH
44.9121906983
210PhosphorylationEDLEFRKSMYEEEIN
HCHHHHHHHHHHHHH
23.4923401153
211SulfoxidationDLEFRKSMYEEEINE
CHHHHHHHHHHHHHH
5.6821406390
212PhosphorylationLEFRKSMYEEEINET
HHHHHHHHHHHHHHH
27.5528796482
219PhosphorylationYEEEINETRRKHETR
HHHHHHHHHHHHCEE
31.1427251275
222UbiquitinationEINETRRKHETRLVE
HHHHHHHHHCEEEEE
42.37-
232PhosphorylationTRLVEVDSGRQIEYE
EEEEEECCCCCEEHH
40.8423401153
238PhosphorylationDSGRQIEYEYKLAQA
CCCCCEEHHHHHHHH
26.62-
241SumoylationRQIEYEYKLAQALHE
CCEEHHHHHHHHHHH
25.96-
241AcetylationRQIEYEYKLAQALHE
CCEEHHHHHHHHHHH
25.9626822725
241SumoylationRQIEYEYKLAQALHE
CCEEHHHHHHHHHHH
25.9628112733
241UbiquitinationRQIEYEYKLAQALHE
CCEEHHHHHHHHHHH
25.9621890473
249SulfoxidationLAQALHEMREQHDAQ
HHHHHHHHHHHHHHH
3.8821406390
250MethylationAQALHEMREQHDAQV
HHHHHHHHHHHHHHH
37.12115481627
260PhosphorylationHDAQVRLYKEELEQT
HHHHHHHHHHHHHHH
13.0427642862
261SumoylationDAQVRLYKEELEQTY
HHHHHHHHHHHHHHH
49.67-
261AcetylationDAQVRLYKEELEQTY
HHHHHHHHHHHHHHH
49.6725953088
261SumoylationDAQVRLYKEELEQTY
HHHHHHHHHHHHHHH
49.6728112733
261UbiquitinationDAQVRLYKEELEQTY
HHHHHHHHHHHHHHH
49.6721890473
267PhosphorylationYKEELEQTYHAKLEN
HHHHHHHHHHHHHHH
14.1128152594
268PhosphorylationKEELEQTYHAKLENA
HHHHHHHHHHHHHHH
10.2428152594
271AcetylationLEQTYHAKLENARLS
HHHHHHHHHHHHHHC
42.9219608861
271SumoylationLEQTYHAKLENARLS
HHHHHHHHHHHHHHC
42.9228112733
271UbiquitinationLEQTYHAKLENARLS
HHHHHHHHHHHHHHC
42.9221890473
278PhosphorylationKLENARLSSEMNTST
HHHHHHHCHHCCHHH
20.7830266825
279PhosphorylationLENARLSSEMNTSTV
HHHHHHCHHCCHHHH
45.5230266825
281SulfoxidationNARLSSEMNTSTVNS
HHHHCHHCCHHHHHH
7.7721406390
283PhosphorylationRLSSEMNTSTVNSAR
HHCHHCCHHHHHHHH
25.1930266825
284PhosphorylationLSSEMNTSTVNSARE
HCHHCCHHHHHHHHH
25.9223401153
285PhosphorylationSSEMNTSTVNSAREE
CHHCCHHHHHHHHHH
22.9730266825
288PhosphorylationMNTSTVNSAREELME
CCHHHHHHHHHHHHH
25.1130266825
297MethylationREELMESRMRIESLS
HHHHHHHHHHHHHHH
12.70115481611
299MethylationELMESRMRIESLSSQ
HHHHHHHHHHHHHHH
28.54115481643
302PhosphorylationESRMRIESLSSQLSN
HHHHHHHHHHHHHHH
31.0530266825
304PhosphorylationRMRIESLSSQLSNLQ
HHHHHHHHHHHHHHH
25.8930266825
305PhosphorylationMRIESLSSQLSNLQK
HHHHHHHHHHHHHHH
40.2030266825
308PhosphorylationESLSSQLSNLQKESR
HHHHHHHHHHHHHHH
28.0526074081
312AcetylationSQLSNLQKESRACLE
HHHHHHHHHHHHHHH
61.9025953088
312MalonylationSQLSNLQKESRACLE
HHHHHHHHHHHHHHH
61.9026320211
312SumoylationSQLSNLQKESRACLE
HHHHHHHHHHHHHHH
61.9028112733
312UbiquitinationSQLSNLQKESRACLE
HHHHHHHHHHHHHHH
61.9021890473
330AcetylationELEDLLAKEKDNSRR
HHHHHHHHCCCCHHC
66.3325953088
330SumoylationELEDLLAKEKDNSRR
HHHHHHHHCCCCHHC
66.3328112733
330UbiquitinationELEDLLAKEKDNSRR
HHHHHHHHCCCCHHC
66.3321906983
340PhosphorylationDNSRRMLTDKEREMA
CCHHCCCCHHHHHHH
35.3621406692
342AcetylationSRRMLTDKEREMAEI
HHCCCCHHHHHHHHH
54.1325953088
342UbiquitinationSRRMLTDKEREMAEI
HHCCCCHHHHHHHHH
54.13-
353SulfoxidationMAEIRDQMQQQLNDY
HHHHHHHHHHHHCCH
4.5628465586
360PhosphorylationMQQQLNDYEQLLDVK
HHHHHCCHHHHHHHH
12.4228796482
375PhosphorylationLALDMEISAYRKLLE
HHHHCHHHHHHHHHC
13.1230266825
377PhosphorylationLDMEISAYRKLLEGE
HHCHHHHHHHHHCCH
11.0723403867
379SumoylationMEISAYRKLLEGEEE
CHHHHHHHHHCCHHH
44.76-
379AcetylationMEISAYRKLLEGEEE
CHHHHHHHHHCCHHH
44.7622631273
379SumoylationMEISAYRKLLEGEEE
CHHHHHHHHHCCHHH
44.76-
379UbiquitinationMEISAYRKLLEGEEE
CHHHHHHHHHCCHHH
44.7621906983
387MethylationLLEGEEERLKLSPSP
HHCCHHHHHCCCCCC
40.16-
389SumoylationEGEEERLKLSPSPSS
CCHHHHHCCCCCCCC
53.81-
389AcetylationEGEEERLKLSPSPSS
CCHHHHHCCCCCCCC
53.8125953088
389SumoylationEGEEERLKLSPSPSS
CCHHHHHCCCCCCCC
53.81-
389UbiquitinationEGEEERLKLSPSPSS
CCHHHHHCCCCCCCC
53.8121890473
391PhosphorylationEEERLKLSPSPSSRV
HHHHHCCCCCCCCCE
23.0329255136
393PhosphorylationERLKLSPSPSSRVTV
HHHCCCCCCCCCEEE
33.7629255136
395PhosphorylationLKLSPSPSSRVTVSR
HCCCCCCCCCEEEEC
34.8029255136
396PhosphorylationKLSPSPSSRVTVSRA
CCCCCCCCCEEEECC
33.8729255136
399PhosphorylationPSPSSRVTVSRASSS
CCCCCCEEEECCCCC
16.2030266825
401O-linked_GlycosylationPSSRVTVSRASSSRS
CCCCEEEECCCCCCC
16.8628510447
401PhosphorylationPSSRVTVSRASSSRS
CCCCEEEECCCCCCC
16.8623401153
404PhosphorylationRVTVSRASSSRSVRT
CEEEECCCCCCCCCC
27.9523927012
405PhosphorylationVTVSRASSSRSVRTT
EEEECCCCCCCCCCC
28.8730266825
406PhosphorylationTVSRASSSRSVRTTR
EEECCCCCCCCCCCC
26.5330266825
408PhosphorylationSRASSSRSVRTTRGK
ECCCCCCCCCCCCCC
20.2127273156
411PhosphorylationSSSRSVRTTRGKRKR
CCCCCCCCCCCCCEE
20.7726074081
412PhosphorylationSSRSVRTTRGKRKRV
CCCCCCCCCCCCEEC
27.1926074081
413MethylationSRSVRTTRGKRKRVD
CCCCCCCCCCCEECC
48.28-
457UbiquitinationDGKFIRLKNTSEQDQ
CCCEEEEECCCCCCC
48.62-
460PhosphorylationFIRLKNTSEQDQPMG
EEEEECCCCCCCCCC
42.53-
474AcetylationGGWEMIRKIGDTSVS
CCHHHHHHHCCCEEE
39.8726051181
474MalonylationGGWEMIRKIGDTSVS
CCHHHHHHHCCCEEE
39.8726320211
474UbiquitinationGGWEMIRKIGDTSVS
CCHHHHHHHCCCEEE
39.87-
478PhosphorylationMIRKIGDTSVSYKYT
HHHHHCCCEEEEEEE
26.3023186163
479PhosphorylationIRKIGDTSVSYKYTS
HHHHCCCEEEEEEEE
17.5121815630
481PhosphorylationKIGDTSVSYKYTSRY
HHCCCEEEEEEEEEE
18.7030108239
482NitrationIGDTSVSYKYTSRYV
HCCCEEEEEEEEEEE
13.08-
483AcetylationGDTSVSYKYTSRYVL
CCCEEEEEEEEEEEE
34.2519608861
483UbiquitinationGDTSVSYKYTSRYVL
CCCEEEEEEEEEEEE
34.2521890473
484PhosphorylationDTSVSYKYTSRYVLK
CCEEEEEEEEEEEEE
11.1723882029
506PhosphorylationWAANAGVTASPPTDL
EEECCCCCCCCCCEE
22.0928348404
508PhosphorylationANAGVTASPPTDLIW
ECCCCCCCCCCEEEE
23.2628348404
528AcetylationWGTGEDVKVILKNSQ
CCCCCCEEEEEECCC
35.5625953088
528UbiquitinationWGTGEDVKVILKNSQ
CCCCCCEEEEEECCC
35.5621890473
532AcetylationEDVKVILKNSQGEEV
CCEEEEEECCCCCCH
43.3525825284
532MalonylationEDVKVILKNSQGEEV
CCEEEEEECCCCCCH
43.3526320211
532SumoylationEDVKVILKNSQGEEV
CCEEEEEECCCCCCH
43.3528112733
532UbiquitinationEDVKVILKNSQGEEV
CCEEEEEECCCCCCH
43.3521890473
534PhosphorylationVKVILKNSQGEEVAQ
EEEEEECCCCCCHHH
37.6725159151
543PhosphorylationGEEVAQRSTVFKTTI
CCCHHHHCEEEEECC
19.4928450419
544PhosphorylationEEVAQRSTVFKTTIP
CCHHHHCEEEEECCC
31.9528450419
547AcetylationAQRSTVFKTTIPEEE
HHHCEEEEECCCHHH
40.1826051181
547SumoylationAQRSTVFKTTIPEEE
HHHCEEEEECCCHHH
40.1828112733
547UbiquitinationAQRSTVFKTTIPEEE
HHHCEEEEECCCHHH
40.182190698
548PhosphorylationQRSTVFKTTIPEEEE
HHCEEEEECCCHHHH
20.6325849741
549PhosphorylationRSTVFKTTIPEEEEE
HCEEEEECCCHHHHH
34.8225849741
575PhosphorylationELFHQQGTPRASNRS
HHHHCCCCCCCCCCC
12.7925159151
579PhosphorylationQQGTPRASNRSCAIM
CCCCCCCCCCCCCCC
33.7719007248
583FarnesylationPRASNRSCAIM----
CCCCCCCCCCC----
2.412684976
583FarnesylationPRASNRSCAIM----
CCCCCCCCCCC----
2.412684976
583MethylationPRASNRSCAIM----
CCCCCCCCCCC----
2.4110679189

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
23SPhosphorylationKinaseCDK1P06493
PSP
23SPhosphorylationKinaseCDK-FAMILY-GPS
23SPhosphorylationKinaseCDK_GROUP-PhosphoELM
393SPhosphorylationKinaseCDK1P06493
PSP
393SPhosphorylationKinaseCDK-FAMILY-GPS
393SPhosphorylationKinaseCDK_GROUP-PhosphoELM
395SPhosphorylationKinaseKPCBP05771
PhosphoELM
395SPhosphorylationKinasePRKCBP05771-2
GPS
396SPhosphorylationKinasePKC-FAMILY-GPS
396SPhosphorylationKinasePKC_GROUP-PhosphoELM
405SPhosphorylationKinaseKPCBP05771
PhosphoELM
405SPhosphorylationKinasePRKCBP05771-2
GPS
406SPhosphorylationKinasePKC-FAMILY-GPS
406SPhosphorylationKinasePKC_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LMNB1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LMNB1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
KPCA_HUMANPRKCAphysical
12135703
NDEL1_HUMANNDEL1physical
19198602
AIRE_HUMANAIREphysical
20085707
PO2F1_HUMANPOU2F1physical
21897860
PCGF2_HUMANPCGF2physical
19727227
LMNA_HUMANLMNAphysical
19727227
EGF_HUMANEGFphysical
19727227
NICA_HUMANNCSTNphysical
22939629
MAGT1_HUMANMAGT1physical
22939629
URB2_HUMANURB2physical
15265697
AACT_HUMANSERPINA3physical
21988832
MBIP1_HUMANMBIPphysical
21988832
ZZEF1_HUMANZZEF1physical
22863883
IMA3_HUMANKPNA4physical
26344197
RFA1_HUMANRPA1physical
26344197
RFA3_HUMANRPA3physical
26344197
SF3B3_HUMANSF3B3physical
26344197
SRSF6_HUMANSRSF6physical
26344197
PIAS2_HUMANPIAS2physical
21516116
MLP3B_HUMANMAP1LC3Bphysical
26524528
LMNA_HUMANLMNAphysical
26524528
LMNB2_HUMANLMNB2physical
26524528

Drug and Disease Associations
Kegg Disease
OMIM Disease
169500Leukodystrophy, demyelinating, autosomal dominant, adult-onset (ADLD)
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LMNB1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-5; THR-20 AND SER-23, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-157; LYS-271 AND LYS-483,AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20; SER-23; SER-375 ANDTHR-575, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-5; THR-20 AND SER-23, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20; SER-23 AND THR-575,AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20 AND SER-23, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-278; SER-279;SER-284; SER-391 AND SER-579, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20; SER-23 AND SER-391,AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20 AND SER-23, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-23; SER-28;SER-200; SER-404 AND THR-575, AND MASS SPECTROMETRY.
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
Kim J.-E., Tannenbaum S.R., White F.M.;
J. Proteome Res. 4:1339-1346(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391 AND SER-393, ANDMASS SPECTROMETRY.
Prenylation
ReferencePubMed
"Human lamin B contains a farnesylated cysteine residue.";
Farnsworth C.C., Wolda S.L., Gelb M.H., Glomset J.A.;
J. Biol. Chem. 264:20422-20429(1989).
Cited for: ISOPRENYLATION AT CYS-583.

TOP